Literature DB >> 27229901

Nanoparticles and direct immunosuppression.

Terrika A Ngobili1, Michael A Daniele2.   

Abstract

Targeting the immune system with nanomaterials is an intensely active area of research. Specifically, the capability to induce immunosuppression is a promising complement for drug delivery and regenerative medicine therapies. Many novel strategies for immunosuppression rely on nanoparticles as delivery vehicles for small-molecule immunosuppressive compounds. As a consequence, efforts in understanding the mechanisms in which nanoparticles directly interact with the immune system have been overshadowed. The immunological activity of nanoparticles is dependent on the physiochemical properties of the nanoparticles and its subsequent cellular internalization. As the underlying factors for these reactions are elucidated, more nanoparticles may be engineered and evaluated for inducing immunosuppression and complementing immunosuppressive drugs. This review will briefly summarize the state-of-the-art and developments in understanding how nanoparticles induce immunosuppressive responses, compare the inherent properties of nanomaterials which induce these immunological reactions, and comment on the potential for using nanomaterials to modulate and control the immune system.
© 2016 by the Society for Experimental Biology and Medicine.

Keywords:  Nanoparticles; anti-inflammatory; bionanoscience; immunosuppression; immunotoxicity; nanotoxicology

Mesh:

Substances:

Year:  2016        PMID: 27229901      PMCID: PMC4950368          DOI: 10.1177/1535370216650053

Source DB:  PubMed          Journal:  Exp Biol Med (Maywood)        ISSN: 1535-3699


  106 in total

1.  Self-assembled peptide amphiphile micelles containing a cytotoxic T-cell epitope promote a protective immune response in vivo.

Authors:  Matthew Black; Amanda Trent; Yulia Kostenko; Joseph Saeyong Lee; Colleen Olive; Matthew Tirrell
Journal:  Adv Mater       Date:  2012-05-02       Impact factor: 30.849

2.  A self-assembling peptide acting as an immune adjuvant.

Authors:  Jai S Rudra; Ye F Tian; Jangwook P Jung; Joel H Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-22       Impact factor: 11.205

Review 3.  Pharmacogenetics and immunosuppressive drugs in solid organ transplantation.

Authors:  Teun van Gelder; Ron H van Schaik; Dennis A Hesselink
Journal:  Nat Rev Nephrol       Date:  2014-09-23       Impact factor: 28.314

4.  Antioxidant properties of cerium oxide nanocrystals as a function of nanocrystal diameter and surface coating.

Authors:  Seung Soo Lee; Wensi Song; Minjung Cho; Hema L Puppala; Phuc Nguyen; Huiguang Zhu; Laura Segatori; Vicki L Colvin
Journal:  ACS Nano       Date:  2013-10-21       Impact factor: 15.881

5.  Immunosuppressive nano-therapeutic micelles downregulate endothelial cell inflammation and immunogenicity.

Authors:  Satish N Nadig; Suraj K Dixit; Natalie Levey; Scott Esckilsen; Kayla Miller; William Dennis; Carl Atkinson; Ann-Marie Broome
Journal:  RSC Adv       Date:  2015-04-24       Impact factor: 3.361

6.  Polyvalent dendrimer glucosamine conjugates prevent scar tissue formation.

Authors:  Sunil Shaunak; Sharyn Thomas; Elisabetta Gianasi; Antony Godwin; Emma Jones; Ian Teo; Kamiar Mireskandari; Philip Luthert; Ruth Duncan; Steve Patterson; Peng Khaw; Steve Brocchini
Journal:  Nat Biotechnol       Date:  2004-07-18       Impact factor: 54.908

7.  The Influences of Cell Type and ZnO Nanoparticle Size on Immune Cell Cytotoxicity and Cytokine Induction.

Authors:  Cory Hanley; Aaron Thurber; Charles Hanna; Alex Punnoose; Jianhui Zhang; Denise G Wingett
Journal:  Nanoscale Res Lett       Date:  2009-09-16       Impact factor: 4.703

8.  Toxicity of antimony trioxide nanoparticles on human hematopoietic progenitor cells and comparison to cell lines.

Authors:  Lisa Bregoli; Francesca Chiarini; Andrea Gambarelli; Gianluca Sighinolfi; Antonietta M Gatti; Patrizia Santi; Alberto M Martelli; Lucio Cocco
Journal:  Toxicology       Date:  2009-05-29       Impact factor: 4.221

9.  Gold nanoparticles downregulate interleukin-1β-induced pro-inflammatory responses.

Authors:  Vadim V Sumbayev; Inna M Yasinska; Cesar Pascual Garcia; Douglas Gilliland; Gurprit S Lall; Bernhard F Gibbs; David R Bonsall; Luca Varani; François Rossi; Luigi Calzolai
Journal:  Small       Date:  2012-10-30       Impact factor: 13.281

10.  In vivo study of spherical gold nanoparticles: inflammatory effects and distribution in mice.

Authors:  Hui Chen; Alisha Dorrigan; Sonia Saad; Dominic J Hare; Michael B Cortie; Stella M Valenzuela
Journal:  PLoS One       Date:  2013-02-28       Impact factor: 3.240

View more
  14 in total

Review 1.  Cancer therapy with iron oxide nanoparticles: Agents of thermal and immune therapies.

Authors:  Frederik Soetaert; Preethi Korangath; David Serantes; Steven Fiering; Robert Ivkov
Journal:  Adv Drug Deliv Rev       Date:  2020-06-27       Impact factor: 15.470

2.  Neuro-Nano Interfaces: Utilizing Nano-Coatings and Nanoparticles to Enable Next-Generation Electrophysiological Recording, Neural Stimulation, and Biochemical Modulation.

Authors:  Ashlyn T Young; Neil Cornwell; Michael A Daniele
Journal:  Adv Funct Mater       Date:  2017-06-07       Impact factor: 18.808

Review 3.  Mechanisms of immune response to inorganic nanoparticles and their degradation products.

Authors:  Raziye Mohammapdour; Hamidreza Ghandehari
Journal:  Adv Drug Deliv Rev       Date:  2021-11-02       Impact factor: 15.470

4.  Bionized Nanoferrite Particles Alter the Course of Experimental Cryptococcus neoformans Pneumonia.

Authors:  Livia C Liporagi Lopes; Preethi Korangath; Robert Ivkov; Samuel R Dos Santos; Kathleen L Gabrielson; Arturo Casadevall
Journal:  Antimicrob Agents Chemother       Date:  2022-03-16       Impact factor: 5.938

Review 5.  Biocompatibility of nanomaterials and their immunological properties.

Authors:  Themis R Kyriakides; Arindam Raj; Tiffany H Tseng; Hugh Xiao; Ryan Nguyen; Farrah S Mohammed; Saiti Halder; Mengqing Xu; Michelle J Wu; Shuozhen Bao; Wendy C Sheu
Journal:  Biomed Mater       Date:  2021-03-11       Impact factor: 3.715

Review 6.  Emerging Role of Immunosuppression in Diseases Induced by Micro- and Nano-Particles: Time to Revisit the Exclusive Inflammatory Scenario.

Authors:  François Huaux
Journal:  Front Immunol       Date:  2018-11-19       Impact factor: 7.561

Review 7.  Immune Relevant and Immune Deficient Mice: Options and Opportunities in Translational Research.

Authors:  Enrico Radaelli; Sara F Santagostino; Rani S Sellers; Cory F Brayton
Journal:  ILAR J       Date:  2018-12-31

8.  Iron Oxide Colloidal Nanoclusters as Theranostic Vehicles and Their Interactions at the Cellular Level.

Authors:  Athanasia Kostopoulou; Konstantinos Brintakis; Eirini Fragogeorgi; Amalia Anthousi; Liberato Manna; Sylvie Begin-Colin; Claire Billotey; Anthi Ranella; George Loudos; Irene Athanassakis; Alexandros Lappas
Journal:  Nanomaterials (Basel)       Date:  2018-05-09       Impact factor: 5.076

Review 9.  The Impact of Engineered Silver Nanomaterials on the Immune System.

Authors:  Neethu Ninan; Nirmal Goswami; Krasimir Vasilev
Journal:  Nanomaterials (Basel)       Date:  2020-05-18       Impact factor: 5.719

10.  Bridging the gap between toxicity and carcinogenicity of mineral fibres by connecting the fibre crystal-chemical and physical parameters to the key characteristics of cancer.

Authors:  Alessandro F Gualtieri
Journal:  Curr Res Toxicol       Date:  2021-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.